GO:1904026 regulation of collagen fibril organization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904026 (regulation of collagen fibril organization) is a biological process that modulates the frequency, rate or extent of collagen fibril organization, a key step in extracellular matrix assembly [1, 2].
• Collagen fibril organization is controlled by heterotypic interactions between fibrillar collagens (e.g., type I, V, XI) and regulatory molecules such as decorin, which influence fibril diameter, spacing, and macrostructure [4, 6, 8].
• Mechanical loading and tissue-specific fibroblasts dynamically regulate collagen fibril organization during development, aging, and repair [1, 2, 5].
• Disrupted regulation of collagen fibril organization contributes to tendon and corneal pathologies, fibrosis, and cardiovascular remodeling [3, 4, 5, 7].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes controlling collagen fibril organization [1, 4, 6].
• Single-cell transcriptomics and multi-omic approaches are revealing fibroblast and macrophage subsets that modulate collagen fibril organization in disease [5, 7].
Description
Collagen fibril organization is the process by which collagen molecules assemble into ordered fibrils that provide structural support to tissues. The Gene Ontology term GO:1904026, regulation of collagen fibril organization, describes any process that modulates the frequency, rate or extent of this assembly [1, 2]. This regulatory process is essential for the mechanical integrity of tendons, cornea, skin, and blood vessels, and its dysregulation is linked to a range of human diseases [3, 4, 5]. Understanding how collagen fibril organization is regulated requires integrating knowledge of extracellular matrix components, cell-matrix interactions, and mechanical cues [1, 2, 8]. Recent advances in single-cell transcriptomics and multi-omic profiling have begun to uncover the cellular heterogeneity that underlies this regulation in health and disease [5, 7]. This article provides a research-grade overview of GO:1904026, covering its definition, mechanisms, key genes, disease relevance, and experimental models for study.
regulation of collagen fibril organization At A Glance
| GO ID | GO:1904026 |
|---|---|
| GO term | regulation of collagen fibril organization |
| Ontology | biological_process |
| Synonym | regulation of collagen fibrillogenesis; regulation of collagen fibril organisation; regulation of fibrillar collagen organization |
| Major function | Modulates the frequency, rate or extent of collagen fibril organization, influencing extracellular matrix architecture and tissue mechanics |
| Related processes | Collagen fibril organization (GO:0030199), extracellular matrix organization (GO:0030198), collagen biosynthetic process (GO:0032964) |
| Key regulators | Fibrillar collagens (COL1A1, COL1A2, COL5A1, COL11A1), proteoglycans (decorin), and mechanical loading |
| Tissue contexts | Tendon, cornea, skin, blood vessels, endometrium |
What Is GO:1904026?
GO:1904026 is defined as any process that modulates the frequency, rate or extent of collagen fibril organization. In other words, it encompasses the molecular and cellular events that control how collagen molecules are assembled into fibrils, including the regulation of fibril nucleation, growth, diameter, spacing, and three-dimensional arrangement. This term is a biological process and includes synonyms such as regulation of collagen fibrillogenesis, regulation of collagen fibril organisation, and regulation of fibrillar collagen organization.
Why Is regulation of collagen fibril organization Important in Cell Biology?
Regulation of collagen fibril organization is critical for the structural and functional integrity of connective tissues. It determines the mechanical properties of tendons, the transparency of the cornea, and the tensile strength of skin and blood vessels [1, 3, 4]. Dysregulation of this process is associated with a spectrum of disorders, including tendon injuries, corneal dystrophies, fibrosis, and cardiovascular remodeling [3, 4, 5, 7]. Moreover, understanding how collagen fibril organization is regulated at the cellular and molecular level can inform regenerative medicine strategies and the development of targeted therapies for matrix-related diseases [2, 6, 8].
• Maintains tissue mechanical properties in tendon, cornea, skin, and blood vessels [1, 3, 4].
• Dysregulation leads to tendon degeneration and impaired healing [1, 4].
• Corneal transparency depends on precise regulation of collagen fibril organization.
• Decorin deficiency alters collagen fibril organization in the endometrium, affecting pregnancy.
• Ageing and serum cholesterol affect fibroblast subsets that regulate collagen fibril organization.
• Macrophage subsets modulate collagen fibril organization after myocardial infarction.
• Type V collagen regulates heterotypic type I/V collagen interactions during fibril assembly.
• Collagen XI regulates acquisition of fibril structure and functional properties in tendon.
• Skin aging involves extracellular matrix regulation of fibroblast function.
• CRISPR models enable causal testing of genes in collagen fibril organization [1, 4, 6].
What Happens During regulation of collagen fibril organization?
Initiation of collagen fibril assembly
In simple terms: Collagen molecules start to come together to form tiny fibrils.
Collagen fibril organization begins with the synthesis and secretion of fibrillar collagen molecules, primarily type I collagen, which then undergo processing and self-assembly into fibrils. Type V collagen plays a critical role in nucleating fibril assembly by forming heterotypic interactions with type I collagen, thereby regulating the initiation and early growth of fibrils. In tendon, collagen XI similarly regulates the acquisition of fibril structure and organization. These initial steps are tightly controlled to ensure proper fibril diameter and spacing.
Regulation by proteoglycans and matrix molecules
In simple terms: Other molecules in the matrix act like referees to control how fibrils grow and arrange.
Proteoglycans such as decorin bind to collagen fibrils and regulate their organization by influencing fibril diameter and spacing. In decorin-deficient mice, collagen fibril organization in the pregnant endometrium is altered, demonstrating that decorin is a key regulator of fibril macrostructure. Similarly, extracellular matrix components modulate fibroblast function during skin aging, affecting collagen fibril organization. These regulatory molecules ensure that fibrils assemble into functional networks tailored to specific tissues.
Mechanical loading and cellular regulation
In simple terms: Physical forces and cells work together to shape collagen fibrils.
Mechanical loading is a potent regulator of collagen fibril organization in tendon. Tendon cells respond to mechanical cues by adjusting collagen synthesis and matrix remodeling, thereby altering fibril organization to meet mechanical demands. Fibroblasts, the primary cells responsible for collagen production, are heterogeneous and differentially affected by ageing and serum cholesterol, which impacts their ability to regulate collagen fibril organization. Thus, both mechanical and cellular factors converge to regulate this process [1, 5].
Tissue-specific macrostructure and morphogenesis
In simple terms: Different tissues have unique ways of arranging collagen fibrils to suit their function.
During corneal morphogenesis, cell regulation of collagen fibril macrostructure is essential for achieving transparency and refractive properties. In tendon, collagen XI regulates the acquisition of fibril structure and functional properties, highlighting tissue-specific regulatory mechanisms. These examples illustrate that regulation of collagen fibril organization is adapted to the developmental and functional requirements of each tissue [3, 4].
Dynamic remodeling in disease and repair
In simple terms: When tissues are injured or diseased, collagen fibril organization changes dynamically.
After myocardial infarction, macrophage subsets modulate collagen fibril organization as part of the inflammatory and reparative response. Ageing and serum cholesterol alter fibroblast clusters that regulate collagen fibril organization, contributing to cardiovascular remodeling. These dynamic changes underscore the importance of understanding regulatory mechanisms in both homeostasis and disease [5, 7].
Key Genes Involved in GO:1904026 regulation of collagen fibril organization
The following genes and proteins are key players in the regulation of collagen fibril organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Major fibrillar collagen; forms the core of collagen fibrils | Central to fibril assembly; mutations cause osteogenesis imperfecta |
| COL1A2 | Fibrillar collagen; heterotrimer with COL1A1 | Essential for fibril structure; mutations affect matrix stability |
| COL5A1 | Regulates heterotypic type I/V collagen interactions and fibril nucleation | Key regulator of fibril assembly; mutations linked to Ehlers-Danlos syndrome |
| COL11A1 | Regulates acquisition of collagen fibril structure in tendon | Critical for tendon fibril organization and function |
| DCN | Decorin; proteoglycan that regulates fibril diameter and spacing | Decorin deficiency alters endometrial collagen fibril organization |
| LUM | Lumican; proteoglycan involved in fibril organization | Modulates collagen fibril assembly in cornea and other tissues |
| FMOD | Fibromodulin; regulates collagen fibrillogenesis | Influences tendon and corneal fibril organization |
| MMP1 | Matrix metalloproteinase 1; degrades collagen | Remodeling of collagen fibrils in aging and disease |
| MMP2 | Matrix metalloproteinase 2; degrades collagen | Involved in matrix remodeling after injury |
| TGFB1 | Cytokine that promotes collagen synthesis | Regulates fibroblast-mediated collagen fibril organization |
| LOX | Lysyl oxidase; crosslinks collagen fibrils | Crosslinking stabilizes fibril organization |
| POSTN | Periostin; matricellular protein that regulates collagen fibrillogenesis | Important in tendon and corneal matrix organization |
| FN1 | Fibronectin; guides collagen fibril assembly | Facilitates cell-matrix interactions during fibril organization |
| ITGB1 | Integrin beta 1; mediates cell-collagen interactions | Signals mechanical cues to regulate fibril organization |
| VIM | Vimentin; intermediate filament protein in fibroblasts | Supports fibroblast function in collagen regulation |
| ACTA2 | Alpha-smooth muscle actin; myofibroblast marker | Myofibroblasts regulate collagen fibril organization in fibrosis |
| CD68 | Macrophage marker | Macrophage subsets modulate collagen fibril organization post-MI |
How Is regulation of collagen fibril organization Regulated?
Regulation of collagen fibril organization is controlled at multiple levels. Mechanical loading directly influences tendon cell biology and collagen fibril organization. Cytokines such as TGFB1 promote collagen synthesis and modulate fibroblast function. Proteoglycans like decorin act as regulators of fibril diameter and spacing. In disease states, macrophage subsets and fibroblast clusters dynamically regulate collagen fibril organization, as seen after myocardial infarction and in cardiovascular remodeling [5, 7]. These regulatory mechanisms ensure that collagen fibril organization adapts to physiological demands and responds to injury.
regulation of collagen fibril organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL5A1 | Ehlers-Danlos syndrome; impaired fibril assembly | Knockout or point mutation in COL5A1 in fibroblasts |
| COL11A1 | Tendon dysfunction; altered fibril structure | Knockout in tendon cells |
| DCN | Endometrial collagen fibril disorganization | Decorin-deficient mouse model |
| MMP1 | Skin aging; collagen degradation | Overexpression in dermal fibroblasts |
| TGFB1 | Fibrosis; excessive collagen deposition | Knock-in of constitutively active TGFB1 |
Tendon and musculoskeletal disorders
Disrupted regulation of collagen fibril organization contributes to tendon degeneration and impaired healing. Mechanical loading is a key regulator of tendon cell biology, and alterations in this process can lead to tendinopathy. Collagen XI regulates the acquisition of fibril structure in tendon, and its dysfunction may impair tendon mechanical properties.
Corneal dystrophies and vision disorders
Corneal transparency depends on precise regulation of collagen fibril organization. Cell regulation of collagen fibril macrostructure during corneal morphogenesis is essential, and its disruption can lead to corneal opacity and dystrophies.
Cardiovascular remodeling and fibrosis
After myocardial infarction, macrophage subsets modulate collagen fibril organization as part of the reparative response. Ageing and serum cholesterol affect fibroblast clusters that regulate collagen fibril organization, contributing to cardiovascular remodeling and fibrosis.
Endometrial and reproductive disorders
Decorin deficiency alters collagen fibril organization in the pregnant endometrium, suggesting that dysregulation of this process may affect pregnancy and reproductive outcomes.
From regulation of collagen fibril organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does COL5A1 regulate collagen fibril nucleation? | COL5A1 knockout fibroblasts |
| How does decorin affect endometrial fibril organization? | Decorin knockout mouse |
| What is the role of collagen XI in tendon fibril structure? | COL11A1 knockout tendon cells |
| How does mechanical loading alter collagen fibril organization? | In vitro tendon cell stretching model |
| Do macrophage subsets modulate collagen fibril organization post-MI? | Macrophage-specific knockout in mouse MI model |
| How does ageing affect fibroblast regulation of collagen fibrils? | Single-cell transcriptomics of aged fibroblasts |
How to Study the regulation of collagen fibril organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transmission electron microscopy | Fibril diameter and spacing | Corneal and tendon fibril organization [3, 4] |
| Second harmonic generation imaging | Collagen fibril orientation and density | Tissue-level organization in cornea and tendon |
| Single-cell RNA sequencing | Cell heterogeneity and gene expression | Identifying fibroblast and macrophage subsets [5, 7] |
| Mechanical testing | Tensile strength and elasticity | Tendon and cardiovascular function [1, 4] |
| Immunohistochemistry | Protein localization and abundance | Collagen and proteoglycan distribution |
| Western blotting | Protein expression levels | Collagen synthesis and processing |
| CRISPR-Cas9 knockout | Gene function loss | Causal testing of regulatory genes [1, 4, 6] |
| Overexpression vectors | Gain-of-function effects | Testing sufficiency of regulators |
Imaging collagen fibril organization
Electron microscopy and second harmonic generation imaging are used to visualize collagen fibril diameter, spacing, and organization in tissues. These methods have been applied to study corneal morphogenesis and tendon fibril structure [3, 4].
Transcriptomic and single-cell analysis
Single-cell RNA sequencing reveals fibroblast and macrophage subsets that regulate collagen fibril organization. This approach has identified fibroblast clusters differentially affected by ageing and serum cholesterol, and macrophage subsets post-myocardial infarction.
Mechanical testing and biomechanics
Mechanical testing measures the functional properties of tissues, such as tendon tensile strength, which reflect collagen fibril organization. These methods are used to assess the impact of regulatory genes [1, 4].
Genetic and molecular perturbation
Knockout, knock-in, and overexpression models in mice and cell lines allow causal testing of genes in collagen fibril organization. For example, decorin-deficient mice have been used to study endometrial fibril organization, and COL5A1 models have elucidated heterotypic interactions.
How CRISPR Can Be Used to Study GO:1904026 regulation of collagen fibril organization
Knockout
CRISPR knockout of genes such as COL5A1, COL11A1, or DCN in fibroblasts or tendon cells can reveal their essential roles in collagen fibril organization. For example, decorin knockout mice show altered endometrial fibril organization, and COL5A1 knockout models have elucidated its role in fibril nucleation.
Point Mutation
Point mutations can mimic disease-associated variants in collagen genes. For instance, specific mutations in COL5A1 linked to Ehlers-Danlos syndrome can be introduced to study their impact on fibril assembly. Similarly, mutations in COL11A1 may affect tendon fibril structure.
Knock-in
Knock-in of tagged or fluorescently labeled collagen genes allows real-time tracking of fibril assembly. This approach can be used to visualize collagen fibril organization dynamics in live cells.
Overexpression
Overexpression of regulatory genes such as TGFB1 or MMP1 can drive excessive collagen deposition or degradation, modeling fibrosis or skin aging. These models help test sufficiency of specific regulators in collagen fibril organization.
How EDITGENE Supports regulation of collagen fibril organization Research
Researchers studying regulation of collagen fibril organization-related genes often need to determine whether a candidate gene is causally involved in fibril assembly, how mutations affect fibril structure, and whether modulating gene expression can rescue or induce disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of collagen fibril organization research.
Frequently Asked Questions About regulation of collagen fibril organization
What is GO:1904026?
GO:1904026 is the Gene Ontology term for regulation of collagen fibril organization, a biological process that modulates the frequency, rate or extent of collagen fibril assembly [1, 2].
What genes are involved in regulation of collagen fibril organization?
Key genes include COL1A1, COL1A2, COL5A1, COL11A1, DCN, LUM, FMOD, MMP1, TGFB1, and LOX, among others [1, 2, 4, 6, 8].
How is collagen fibril organization regulated?
It is regulated by heterotypic collagen interactions, proteoglycans like decorin, mechanical loading, and cellular factors such as fibroblasts and macrophages [1, 2, 6, 7, 8].
What diseases are associated with disrupted collagen fibril organization?
Tendon degeneration, corneal dystrophies, cardiovascular remodeling, fibrosis, and endometrial disorders have been linked to dysregulation of this process [1, 3, 4, 5, 6, 7].
What is the role of decorin in collagen fibril organization?
Decorin is a proteoglycan that regulates collagen fibril diameter and spacing; its deficiency alters endometrial fibril organization in mice.
How does mechanical loading affect collagen fibril organization?
Mechanical loading influences tendon cell biology and collagen fibril organization, adjusting fibril structure to meet mechanical demands.
What experimental models are used to study collagen fibril organization?
Models include knockout mice, CRISPR-edited cell lines, single-cell transcriptomics, and mechanical testing [1, 4, 5, 6, 7].
Can CRISPR be used to study collagen fibril organization?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes regulating collagen fibril organization [1, 4, 6, 8].
What is the role of collagen XI in tendon fibril organization?
Collagen XI regulates the acquisition of collagen fibril structure and functional properties in tendon.
How do macrophage subsets modulate collagen fibril organization after myocardial infarction?
Macrophage subsets dynamically regulate collagen fibril organization as part of the reparative response post-MI.
Conclusion
Regulation of collagen fibril organization (GO:1904026) is a fundamental biological process that controls the assembly and architecture of collagen fibrils in connective tissues. Its dysregulation underlies a variety of diseases, from tendon injuries to cardiovascular fibrosis. Advances in CRISPR genome editing, single-cell transcriptomics, and imaging are providing unprecedented insights into the genes and cellular players that regulate this process. EDITGENE offers a full suite of services to support mechanistic studies and therapeutic development targeting collagen fibril organization.
References
- 1. Stańczak M et al.. 2024. Tendon Cell Biology: Effect of Mechanical Loading.. Cell Physiol Biochem 58(6):677-701 PMID: 39568406
- 2. Cole MA et al.. 2018. Extracellular matrix regulation of fibroblast function: redefining our perspective on skin aging.. J Cell Commun Signal 12(1):35-43 PMID: 29455303
- 3. Koudouna E et al.. 2018. Cell regulation of collagen fibril macrostructure during corneal morphogenesis.. Acta Biomater 79:96-112 PMID: 30170195
- 4. Sun M et al.. 2020. Collagen XI regulates the acquisition of collagen fibril structure, organization and functional properties in tendon.. Matrix Biol 94:77-94 PMID: 32950601
- 5. van Kuijk K et al.. 2023. Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol.. Cardiovasc Res 119(7):1509-1523 PMID: 36718802
- 6. Sanches JC et al.. 2010. Collagen fibril organization in the pregnant endometrium of decorin-deficient mice.. J Anat 216(1):144-55 PMID: 19900179
- 7. Wu Y et al.. 2025. Temporal dynamics of the multi-omic response reveals the modulation of macrophage subsets post-myocardial infarction.. J Transl Med 23(1):777 PMID: 40640882
- 8. Birk DE. 2001. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly.. Micron 32(3):223-37 PMID: 11006503
